Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FYSIOTERAPI OG AKUPUNKTUR ApS JAKOB ANDREASEN Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   0.8% 0.7% 0.7% 1.1% 0.7% 0.8% 9.9% 9.9%   Credit score (0-100)   93 94 93 83 92 93 25 25   Credit rating   AA AA AA A AA AA BB BB   Credit limit (kDKK)   224.9 241.0 243.2 85.8 246.5 247.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   965 943 1,022 1,029 987 1,028 0.0 0.0   EBITDA   393 386 444 371 326 306 0.0 0.0   EBIT   332 325 387 314 266 246 0.0 0.0   Pre-tax profit (PTP)   364.0 337.0 438.0 75.0 383.0 239.2 0.0 0.0   Net earnings   270.0 248.0 329.0 67.0 285.0 172.3 0.0 0.0   Pre-tax profit without non-rec. items   364 337 438 75.0 383 239 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   3,883 3,868 3,811 3,917 3,857 3,797 0.0 0.0   Shareholders equity total   1,890 2,030 2,249 2,202 2,374 2,428 2,181 2,181   Interest-bearing liabilities   2,560 2,277 2,194 2,221 2,158 2,089 0.0 0.0   Balance sheet total (assets)   4,694 4,582 4,683 4,568 4,791 4,752 2,181 2,181   Net Debt   1,774 1,601 1,357 1,633 1,298 1,182 -2,181 -2,181     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   965 943 1,022 1,029 987 1,028 0.0 0.0   Gross profit growth   11.3% -2.3% 8.4% 0.7% -4.1% 4.1% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,694 4,582 4,683 4,568 4,791 4,752 2,181 2,181   Balance sheet change%   -0.3% -2.4% 2.2% -2.5% 4.9% -0.8% -54.1% 0.0%   Added value   393.0 386.0 444.0 371.0 323.0 306.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -122 -76 -114 49 -120 -121 -3,797 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   5.0 5.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   34.4% 34.5% 37.9% 30.5% 27.0% 23.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.3% 8.7% 10.8% 7.2% 10.5% 8.0% 0.0% 0.0%   ROI %   9.8% 9.2% 11.4% 7.6% 11.0% 8.4% 0.0% 0.0%   ROE %   14.9% 12.7% 15.4% 3.0% 12.5% 7.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   40.3% 44.3% 48.0% 48.2% 49.6% 51.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   451.4% 414.8% 305.6% 440.2% 398.2% 386.1% 0.0% 0.0%   Gearing %   135.4% 112.2% 97.6% 100.9% 90.9% 86.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.8% 2.7% 2.7% 11.8% 4.9% 6.7% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.9 2.3 3.1 1.8 2.0 2.6 0.0 0.0   Current Ratio   1.9 2.3 3.1 1.8 2.0 2.6 0.0 0.0   Cash and cash equivalent   786.0 676.0 837.0 588.0 860.0 907.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   392.0 352.0 -80.0 -204.0 -272.0 -179.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   393 386 444 371 323 306 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   393 386 444 371 326 306 0 0   EBIT / employee   332 325 387 314 266 246 0 0   Net earnings / employee   270 248 329 67 285 172 0 0